ConductScience.org, home

Paper41665249

The Metabolic State of E. coli Influences Fosfomycin Efficacy and Promotes Resistance Evolution.

Verhülsdonk A and 5 others. ACS Infect Dis, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. The Metabolic State of E. coli Influences Fosfomycin Efficacy and Promotes Resistance Evolution. Papers, record 41665249. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41665249

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Metabolic State of E. coli Influences Fosfomycin Efficacy and Promotes Resistance Evolution.
PubMed
Journal
ACS Infect Dis
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Verhülsdonk AAndreas
2Stadelmann AAmelie
3Smollich FFabianhttps://orcid.org/0009-0009-5048-8917
4Rapp JJohanna
5Straub DDaniel
6Link HHanneshttps://orcid.org/0000-0002-6677-555X

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FosfomycinMajor topic
Escherichia coliMajor topic
Anti-Bacterial AgentsMajor topic
Drug Resistance, BacterialMajor topic
Escherichia coli Proteins
Microbial Sensitivity Tests

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138666213Scalable and efficient DNA sequencing analysis on different compute infrastructures aiding variant discovery.NAR Genom Bioinform2024https://conductscience.org/library/papers/38666213PubMed
231626749Bacterial Heterogeneity and Antibiotic Survival: Understanding and Combatting Persistence and Heteroresistance.Mol Cell2019https://conductscience.org/library/papers/31626749PubMed
326960938Fosfomycin.Clin Microbiol Rev2016https://conductscience.org/library/papers/26960938PubMed
439748127Metabolic mutations reduce antibiotic susceptibility of E. coli by pathway-specific bottlenecks.Mol Syst Biol2025https://conductscience.org/library/papers/39748127PubMed
528197413Mechanism of Reduced Susceptibility to Fosfomycin in Escherichia coli Clinical Isolates.Biomed Res Int2017https://conductscience.org/library/papers/28197413PubMed
633238135Multi-omics Analysis of CRISPRi-Knockdowns Identifies Mechanisms that Buffer Decreases of Enzymes in E. coli Metabolism.Cell Syst2021https://conductscience.org/library/papers/33238135PubMed
736646716Deep mutational scanning of essential bacterial proteins can guide antibiotic development.Nat Commun2023https://conductscience.org/library/papers/36646716PubMed
832756955A genome-wide analysis of Escherichia coli responses to fosfomycin using TraDIS-Xpress reveals novel roles for phosphonate degradation and phosphate transport systems.J Antimicrob Chemother2020https://conductscience.org/library/papers/32756955PubMed
929042431In situ genotyping of a pooled strain library after characterizing complex phenotypes.Mol Syst Biol2017https://conductscience.org/library/papers/29042431PubMed
1030013048Strelka2: fast and accurate calling of germline and somatic variants.Nat Methods2018https://conductscience.org/library/papers/30013048PubMed
1123071270SortMeRNA: fast and accurate filtering of ribosomal RNAs in metatranscriptomic data.Bioinformatics2012https://conductscience.org/library/papers/23071270PubMed
1237666266High prevalence and global distribution of fosfomycin resistance genes in Salmonella serovars.Lancet Microbe2023https://conductscience.org/library/papers/37666266PubMed
1335163052Fosfomycin Resistance Evolutionary Pathways of Stenotrophomonas maltophilia in Different Growing Conditions.Int J Mol Sci2022https://conductscience.org/library/papers/35163052PubMed
148664284
Characterization of a Cys115 to Asp substitution in the Escherichia coli cell wall biosynthetic enzyme UDP-GlcNAc enolpyruvyl transferase (MurA) that confers resistance to inactivation by the antibiotic fosfomycin.
Biochemistry1996https://conductscience.org/library/papers/8664284PubMed
1531279676Bacterial Metabolism and Antibiotic Efficacy.Cell Metab2019https://conductscience.org/library/papers/31279676PubMed
1633274447Understanding tolerance to cell wall-active antibiotics.Ann N Y Acad Sci2021https://conductscience.org/library/papers/33274447PubMed
1720515462Revealing fosfomycin primary effect on Staphylococcus aureus transcriptome: modulation of cell envelope biosynthesis and phosphoenolpyruvate induced starvation.BMC Microbiol2010https://conductscience.org/library/papers/20515462PubMed
1832055031The nf-core framework for community-curated bioinformatics pipelines.Nat Biotechnol2020https://conductscience.org/library/papers/32055031PubMed
1931235888Mechanisms and clinical relevance of bacterial heteroresistance.Nat Rev Microbiol2019https://conductscience.org/library/papers/31235888PubMed
2030423086fastp: an ultra-fast all-in-one FASTQ preprocessor.Bioinformatics2018https://conductscience.org/library/papers/30423086PubMed

See all 37 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41665249

GET https://conductscience.org/api/papers/v1/41665249/references?page=2